Zhejiang Xianju Pharmaceutical Co.,Ltd.

SZSE:002332 Rapporto sulle azioni

Cap. di mercato: CN¥12.0b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Zhejiang Xianju PharmaceuticalLtd Salute del bilancio

Salute finanziaria criteri di controllo 6/6

Zhejiang Xianju PharmaceuticalLtd has a total shareholder equity of CN¥6.0B and total debt of CN¥197.4M, which brings its debt-to-equity ratio to 3.3%. Its total assets and total liabilities are CN¥7.2B and CN¥1.2B respectively. Zhejiang Xianju PharmaceuticalLtd's EBIT is CN¥608.1M making its interest coverage ratio -11.3. It has cash and short-term investments of CN¥1.7B.

Informazioni chiave

3.3%

Rapporto debito/patrimonio netto

CN¥197.42m

Debito

Indice di copertura degli interessi-11.3x
ContantiCN¥1.67b
Patrimonio nettoCN¥5.96b
Totale passivitàCN¥1.23b
Totale attivitàCN¥7.19b

Aggiornamenti recenti sulla salute finanziaria

Nessun aggiornamento

Recent updates

Zhejiang Xianju PharmaceuticalLtd (SZSE:002332) Will Pay A Dividend Of CN¥0.30

Jun 02
Zhejiang Xianju PharmaceuticalLtd (SZSE:002332) Will Pay A Dividend Of CN¥0.30

Estimating The Fair Value Of Zhejiang Xianju Pharmaceutical Co.,Ltd. (SZSE:002332)

Apr 15
Estimating The Fair Value Of Zhejiang Xianju Pharmaceutical Co.,Ltd. (SZSE:002332)

There Is A Reason Zhejiang Xianju Pharmaceutical Co.,Ltd.'s (SZSE:002332) Price Is Undemanding

Mar 05
There Is A Reason Zhejiang Xianju Pharmaceutical Co.,Ltd.'s (SZSE:002332) Price Is Undemanding

Analisi della posizione finanziaria

Passività a breve termine: 002332's short term assets (CN¥3.5B) exceed its short term liabilities (CN¥1.1B).

Passività a lungo termine: 002332's short term assets (CN¥3.5B) exceed its long term liabilities (CN¥110.0M).


Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: 002332 has more cash than its total debt.

Riduzione del debito: 002332's debt to equity ratio has reduced from 63.4% to 3.3% over the past 5 years.

Copertura del debito: 002332's debt is well covered by operating cash flow (321.8%).

Copertura degli interessi: 002332 earns more interest than it pays, so coverage of interest payments is not a concern.


Bilancio


Scoprire le aziende sane